AKT1 and breast cancer: The significance of PI3K/AKT and its potential as a therapeutic target for cancer treatment have been investigated in several types of human cancer in preclinical studies, including renal cancer [15], lung cancer [16], breast cancer [17], glioblastoma [18], and neuroblastoma [19].